Z-2481-2021Class II
BOND Ready-To-Use Primary Antibody CDX2 (EP25), REF PA0375
Leica Microsystems, Inc. / initiated 2021-07-30 / Terminated / root cause: labeling and UDI
Leica Microsystems, Inc. began a recall of BOND Ready-To-Use Primary Antibody CDX2 (EP25), REF PA0375 on . FDA classified it as Class II and gives the reason as "Product may not perform as specified in IFU". As of , the recall status on record is Terminated, and MDM tags the root cause as labeling and UDI.
Recall record
- Recall number
- Z-2481-2021
- Classification
- Class II
- Status
- Terminated
- Initiated
- Posted
- Terminated
- Recalling firm
- Leica Microsystems, Inc.
- Product
- BOND Ready-To-Use Primary Antibody CDX2 (EP25), REF PA0375
- Product code
- NJT Immunohistochemistry Reagents And Kits
- Reason for recall
- Product may not perform as specified in IFU.
- Root cause tag
- labeling and UDI
- FDA root cause
- Unknown/Undetermined by firm
- Action
- The firm notified their consignees by email on 07/30/2021. The notice explained the issue and requested destruction of the product.
- Quantity in commerce
- 237 units
- Distribution
- US Nationwide distribution.
- Product codes and lots
- Product Code PA0375, Lot 69909
Enforcement reports
One row per recalled product line| Recall number | Class | Status | Voluntary or mandated | Report date | Classified |
|---|---|---|---|---|---|
| Z-2481-2021 | Class II | Terminated | Voluntary: Firm initiated |
FIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
